The charts tell me there's trouble here.
The focus when it comes to MRNA is the timing of mRNA-1273, the firm's two dose hopeful protection against Covid.
Kala Pharmaceuticals and Enova International are two companies that have better prospects than the market is pricing in at present.
The 'work from home' or 'economic lockdown' trade is close to being back on.
We are back to square one except for one positive and one negative.
Plus, a quick look at Southwest Airlines and why it remains the one airline to own.
Monday's action in Johnson & Johnson is a fadeable event.
Covid itself, and therapeutics or vaccines associated with taking on the SARS-CoV-2 coronavirus, is under a public microscope.
Let's talk about what's happening right now to get this thing under control and what it will look like not that long from now.
Invest either because of their profitable portfolio, their impressive pipeline, or their technical set-up.